Skip to main content

CAP TODAY/Fujirebio Webinar: CSF Biomarkers: Aid in the Differential Diagnosis of Alzheimer’s Disease

Thank you

This live web event has ended. Thank you for attending.

Description


CSF Biomarkers: Aid in the Differential Diagnosis of Alzheimer’s Disease

Why should you register now for this webinar?
Demand for practical, cost-effective tests to support the diagnosis of
Alzheimer’s disease is increasing with the pending availability of treatment options.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY

What will this webinar empower you to do?
Understand how CSF biomarkers help increase diagnostic accuracy
in patients with and without cognitive impairment
Learn the benefits Aβ42/Aβ40 ratio as an aid in differential diagnosis of
Alzheimer’s disease versus other forms of dementia
Review how to reduce obstacles to pre-analytic and analytic variability of assay results
Ask questions of our distinguished presenters

Contributors

  • Alicia Algeciras-Schimnich, PhD

    Professor of Laboratory Medicine and Pathology
    Department of Laboratory Medicine and Pathology
    Mayo Clinic
    Rochester, MN

  • William T. Hu, MD, PhD, FAAN

    Associate Professor and Chief of Cognitive Neurology
    Rutgers-RWJ Medical School
    Institute for Health, Health Care Policy, and Aging Research
    Rutgers Biomedical and Health Sciences
    New Brunswick, NJ

  • Leslie M. Shaw, PhD

    Professor of Pathology and Laboratory Medicine at the Hospital of the
    University of Pennsylvania
    Director, Clinical Toxicology Laboratory
    University of Pennsylvania Perelman School of Medicine
    Philadelphia, PA

  • Bob McGonnagle

    Publisher, CAP TODAY

September 15, 2021
Wed 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136